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Chapter 3 
 
Application of Highly Active Chiral Ruthenium Catalysts to Asymmetric Ring-Closing 
Olefin Metathesis 
 34 
  
With the successful synthesis of catalysts 1a,b–5a,b completed, studies commenced on 
their application to expanding the scope of ruthenium-catalyzed asymmetric ring-closing 
metathesis (ARCM) and developing ruthenium-catalyzed asymmetric ring-opening cross 
metathesis (AROCM) and asymmetric cross metathesis (ACM).  This chapter describes 
my work on ARCM with Dr. Timothy Funk, who was a graduate student at the time.  We 
reported this work together1 and his complete presentation of the work can be found in 
his thesis.2 
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Figure 3.1. Chiral ruthenium olefin metathesis catalysts. 
 Most ARCM reactions have been catalyzed by chiral molybdenum complexes.3 
For molybdenum-catalyzed ARCM, catalyst to substrate matching is required to obtain 
high ee’s.  For example, complex 6 catalyzes the formation of 5-membered ring 9 with 
high enantioselectivity and yield, but it is inefficient and less selective in generating the 
six-membered ring 11 (Figure 3.2).4  On the other hand, catalyst 7 affords 11 in 98% 
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yield and in >99% ee, but is almost completely inactive in the synthesis of 9.5  More than 
30 chiral molybdenum complexes have been made by varying the imido, alkylidene, and 
bidentate phenoxide groups.3b 
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Figure 3.2.  Catalyst to substrate matching for chiral molybdenum catalysts. 
 As mentioned in Chapter 2, like the parent achiral catalysts, the chiral 
molybdenum complexes are more sensitive to air, moisture, and a variety of common 
functional groups than most ruthenium olefin metathesis catalysts.3b While chiral 
ruthenium catalyst are more user friendly, only one example of a highly enantioselective 
RCM reaction was known as we began our work (Figure 3.3).6  
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THF, 38 °C
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90% ee, 82% yield
12 13
 
Figure 3.3. Lone example of preexisting successful ruthenium-catalyzed ARCM. 
A number of new substrates were examined with catalysts 1a,b–5a,b.  We initially chose 
to test substrates with the same olefin substitution pattern as 12 because this pattern was 
 36 
essential to successful ARCM in the initial report. Thus, substrates were prepared with 
variable linkers attached to the oxygens (14, 16, 18, 20, 22, 24) and an additional 
methylene between the prochiral center and each olefin (26, 28).  These substrates 
allowed us to assess the enantioselectivity of the catalysts in forming a variety of ring-
sizes and compositions (Table 3.1). 
Table 3.1. ARCM with 1–5 
O
Substrate Product
O
O O
O
4a,b 5a,b2a,b
O
O O
2a
35% ee, >98% conv
2b
90% ee, >98% conv
4a
31% ee, >98% conv
4b
84% ee, >98% conv
5a
30% ee, >98% conv
5b
87% ee, >98% conv
2a
68% ee, >98% conv
2b
90% ee, >98% conv
4a
67% ee, >98% conv
4b
88% ee, >98% conv
5a
64% ee, >98% conv
5b
82% ee, 43% conv
2a
65% ee, >98% conv
2b
85% ee, 5% conv
4a
56% ee, >98% conv
4b
87% ee, 51% conv
5a
48% ee, 91% conv
5b
85% ee, 70% conv
2a
65% ee, ~1% conv
2b
85% ee, ~2% conv
4a
57% ee, 4% conv
4b
88% ee, 5% conv
5a
51% ee, 9% conv
5b
0% conv
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23% ee, >95% conv
5b
44% ee, >95% conv
2a
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39% ee, 80% conv
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36% ee, 95% conv
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90% ee, >98% conv
1a
74% ee, >98% conv
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84% ee, 70% conv
1a
76% ee, 93% conv
1b
83% ee, 20% conv
1a
71% ee, ~2% conv
1b
0% conv
1a
92% ee, >98% conv
1b
92% ee, 58% conv
1a
92% ee, 93% conv
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92% ee, 10% conv
1a
80% ee, >98% conv
1b
N/D
1a
31% ee, >95% conv
1b
ND
1a
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Three trends of note emerged from this work: catalyst 2b, which was used in the initial 
ARCM report, proved capable of high enantioselectivity for the ring-closing of a variety 
of other substrates; catalysts 4a,b and 5a,b gave results similar to 2a,b with slight 
increases in ee in some cases and slight decreases in others; on the other hand, catalyst 1a 
emerged as the most selective dichloride catalyst.  The use of a dichloride catalyst is 
advantageous because the dichloride catalysts are more active and stable than the diiodide 
catalysts. Catalysts 1a and 2b were selected as the most generally selective catalysts of 
their classes and were used to obtain isolated yields (Table 3.2). The use of 1a in ARCM 
allowed us to decrease the catalyst loading to as low as 0.8 mol %. 
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Table 3.2.  ARCM reactions of selected achiral trienes with chiral ruthenium catalysts 
 
Triene Product Catalyst (mol %) ee (%)a Conv. (%)b Yield (%) 
O
 
12 
O
 
13 
2b (4) 90 >98 64 
O
 
14 
O
 
15 
2b (4) 90 >98 77 
2b (4) 85 5 ND O
 
16 
O
 
17 1a (2) 76 93 92c 
O
Si
 
20 
O
Si
 
21 
1a (0.8) 92 >98 77d 
O Si
 
24 
O
Si
 
25 
1a (1) 92 65 64 
O
Si
 
28 
O
Si
 
29 
2b (4) 78 >98 98 
Conditions for reactions with 2b: NaI (25 equiv relative to catalyst) and 2a in THF   
(0.055 M in triene) for 1 h at rt, then add triene and stir for 2 h at 40 °C; conditions for 
reactions with 1a: triene, CH2Cl2 (0.055 M in triene), and 1a for 2 h at  40 °C.                   
a Enantiomeric excesses determined by chiral GC.  b Determined  by 1H NMR spectrum 
of crude reaction mixture. c One mol % of 1a is added at the beginning of the reaction, 
and another 1 mol % is added after 2 h.  When 2 mol % of 1a is added at the start with no 
subsequent additions, the yield was only 74%. d Reaction done on a 4 mmol (0.95 g) of 
20 scale.  ND = not determined. 
 
 While we were quite successful in varying the linker attached to the oxygen to 
prepare a variety of ring systems, efforts to vary the olefin substitution patterns were less 
successful (Table 3.3).  Catalysts 2a,b consistently gave poor conversion with substrates 
such as 30, 32, 34, and 36 that had terminal olefins.  This is likely because the 
methylidene of 2a,b is highly unstable.  Strikingly, when other catalysts such as 5a or 1a 
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were used, excellent conversion was observed.  The ee remained poor in all cases, but 
these examples may inform the development of more stable catalysts for olefin 
metathesis reactions that involve a methylidene species and include a phosphine ligand.   
Perhaps more disappointingly, poor ee was obtained when substrate 40 was used, in 
which the methyl groups of 11 have been exchanged for ethyl groups.  This suggests that 
with the current catalyst systems, the substrate scope is relatively limited. 
Table 3.3.  Best results of ARCM reactions with “other” achiral trienes 
Triene Product Catalyst (mol %) ee (%) Conv. (%) 
O
 
30 
O
 
31 
5a (2) 
 
4b (4) 
39 
 
64 
>98 
 
9 
O
Si
Me Me
 
32 
O
Si
 
33 
5a (2) 50 93 
O
 
34 
O
 
35 
5a (2) 
 
4b (4) 
26 
 
61 
>98 
 
9 
O
SiMe
Me
 
36 
O
Si
 
37 
1a (2) 
 
4b (4) 
–8 
 
15 
>98 
 
18 
O
Si
Me Me
 
38 
O
Si
 
39 
(H2IMes)RuCl2(=CHPh) 
(5) NA 
>98 
complex 
mixture 
O
 
40 
O
 
41 
2b (4) 29 >98 
Conditions: 1a or 5a (2 mol %), triene, CH2Cl2 (0.055 M), 40 °C, 2 h; 4a or 2a               
(4 mol %), NaI (25 equiv relative to catalyst), triene, THF (0.055 M), 40 °C, 2 h. NA = 
not applicable. 
 
We sought to develop a model that explains the enantioselectivity in these 
reactions, in order to rationally design more reactive and selective catalysts for ARCM.  
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If the ARCM reaction has a degree of reversibility, a decrease in ee over time would be 
expected.  Although this was not observed, further experiments were performed to 
support the irreversibility of this reaction.  When enantioenriched 21 was exposed to 
achiral catalyst (H2IMes)RuCl2(=CHPh) (42), no erosion of the enantiomeric excess was 
observed, which suggests that once the ring is formed, it does not undergo a secondary 
ring-opening/ring-closing process.  The same conclusion was drawn when 
enantioenriched 12 was heated under 60 psi of ethylene in the presence of 42 (Figure 
3.4).  Under these forcing conditions, the enantiomeric excess of unreacted 12 did not 
erode, and the ethylenolysis product 43 also retained the stereochemistry from the ARCM 
reaction.  
 
42 (5 mol %)
60 psi ethylene
CH2Cl2 (0.055 M)
40 °C, 12 h
O
12
35% ee
83% unreacted
O
12
35% ee
O
43
33% ee
17% conv.  
Figure 3.4.  Ethylenolysis of 12. 
 In the ARCM reactions of the trienes described above, most likely a ruthenium 
alkylidene derived from the least-substituted olefin initially forms.  This species binds 
one of the diastereotopic olefins, and through a metallacyclobutane 
intermediate/transition state, forms the ring-closed product.  Our initial model3c assumed 
olefin coordination occurred cis to the NHC (Scheme 2, lower pathway), on the face 
opposite the isopropyl group (structure 45), and that interaction determined the absolute 
stereochemistry of the product. The interaction of a halide ligand with a substituent on 
the ring of the cyclic intermediate was also proposed to be an important, stereo-defining 
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interaction.7  The actual position of the coordinating olefin relative to the NHC is unclear;  
experimental evidence exists to support olefin binding both cis and trans to the NHC 
(Figure 3.5).8  In the most recent report on this issue,9c Piers and coworkers provide 
compelling evidence for the observation of a 14-electron ruthenacyclobutane trans to the 
NHC.  Computational studies support olefin binding trans to the NHC,9 and a recent 
computational study of 2b reacting with 11 calculated that the diastereotopic olefin 
coordinated trans to the NHC (Scheme 2, upper pathway).10a  Due to the tilt of the ortho-
substituted N-bound aryl ring,10 the alkylidene is positioned underneath the isopropyl 
group (structure 47), which was found to be the “smaller” side of the aryl ring (Figure 
3.6), instead of underneath the ortho C—H bond (structure 46).  In addition to the 
position of the alkylidene determining the absolute stereochemistry of the product, the 
cyclic intermediate formed upon olefin binding is also important.  The pendent olefin not 
involved in the ring-closing reaction prefers to be in the pseudoequatorial position of the 
forming ring.  Although the discussion presented here focuses on a substrate that forms a 
5-membered ring, substrates that form other ring sizes presumably have an energetically 
favored ring conformation once olefin binding occurs.  Therefore the topics mentioned 
above can be extended to other ring-closing substrates.  The importance of the position of 
the substituents on the ring in the cyclic transition state could explain the higher 
enantioselectivities observed for the substrates containing dimethylsilyl groups:  there are 
more nonhydrogen substituents on the ring, and therefore the energy differences for 
various ring conformations are greater than those for substrates with only methylenes in 
the ring.   
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Figure 3.5.  Proposed pathways leading to the desired product. 
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Figure 3.6. Suggested alkylidene position in trans-binding transition state. 
Our initial cis-binding hypothesis was supported by the fact that when a larger 
halide ligand was present, the enantiomeric excess of the product increased.  With recent 
experimental and computational studies providing evidence for olefin binding trans to the 
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NHC, we sought to relate our experimental data to the suggested trans-binding 
mechanism.   If olefin binding occurs trans to the NHC, exchanging the chloride ligands 
for iodides should not have a major steric impact on the transition state.11  Instead, the 
iodide ligands may have an electronic effect.  When the chlorides in the parent achiral 
catalyst 42 were exchanged for iodides, phosphine dissociation occurred more rapidly, 
but the reactivity of the active species did not increase.12  In the case of the chiral 
catalysts 1b-5b, a lower reactivity could increase the enantioselectivity by causing the 
reaction to proceed through a late, more product-like transition state.13  The added steric 
bulk in 1a may hamper its reactivity enough to mimic the electronic deactivation present 
in the diiodide catalysts 2b-5b, resulting in a late transition state and higher degree of 
stereochemical communication between the catalyst and the substrate.  Substrates 32 and 
36, which have alkenes with less steric hindrance compared to substrates 20 and 28, may 
form products in lower enantiomeric excess due to a higher reactivity with the catalyst.  
Although recent studies suggest olefin binding occurs trans to the NHC, and the observed 
absolute stereochemistry can be justified using a proposed model based on trans binding, 
the experimental data does not provide enough support to rule out a cis-binding 
mechanism.   
 
Experimental 
General Information.  NMR spectra were recorded on an Oxford 300 MHz NMR 
spectrometer running Varian VNMR software.  Chemical shifts are reported in parts per 
million (ppm) downfield from tetramethylsilane (TMS) with reference to internal solvent 
for 1H NMR and 13C NMR spectra.  Multiplicities are abbreviated as follows: singlet (s), 
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doublet (d), triplet (t), quartet (q), quintet (quint), sextet (sext), septet (sept), multiplet 
(m), and broad (br).  Optical rotations were taken on a Jasco P-1010 polarimeter with a 
wavelength of 589 nm.  The concentration “c” has units of g/100 mL (or 10 mg/mL) 
unless otherwise noted.  Analytical thin-layer chromatography (TLC) was performed 
using silica gel 60 F254 precoated plates (0.25 mm thickness) with a fluorescent 
indicator.  Visualization was performed with standard potassium permanganate stain (10 
g KMnO4, 20 g Na2CO3, 1 L water) or UV light.  Flash column chromatography was 
performed using silica gel 60 (230–400 mesh).  All enantiomeric purities were 
determined by chiral GC (Chiraldex G-TA, 30 m × 0.25 mm or CP Chirasil-Dex-CB, 25 
m × 0.25 mm) or chiral SFC (supercritical CO2, ADH column, 214 nm UV detection) and 
were compared to racemic samples.  All glassware was either oven dried or flame dried, 
and reactions were done under an atmosphere of argon unless otherwise noted.  All 
organic solvents were dried by passage through solvent purification columns containing 
activated alumina.  All commercial chemicals were used as obtained.  Compounds 30,5 
31,5 32,5 33,5 34,14 35,14 36,14 and 3714 are known compounds. 
 
(2E,5E)-3,5-Dimethylhepta-2,5-dien-4-ol. Titanocene dichloride (444 mg, 1.78 mmol) 
was added to a solution of 2-butyne (5.6 mL, 3.9 g, 71 mmol) and isobutylmagnesium 
bromide (2.0 M in diethyl ether, 33 mL, 66 mmol) in 60 mL Et2O, and the solution stirred 
at rt for 1 h.  Trans-2-methyl-2-butenal (5.7 mL, 5.0 g, 59 mmol) in 30 mL Et2O was 
added slowly, and the mixture stirred at rt for 3 h.  It was quenched with saturated 
aqueous NH4Cl (100 mL), filtered through a pad of Celite, and the organic layer was 
removed from the filtrate.  The aqueous layer was extracted with ether (3 × 75 mL), and 
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the organic layers were combined, washed with brine, dried over MgSO4, and evaporated 
to a brown oil.  The oil was purified by flash chromatography (10% EtOAc in hexanes) to 
a yellow oil, which was distilled (Kugelrohr, 1 torr, 120 °C) to give 7.20 g (86% yield) of 
(2E,5E)-3,5-Dimethylhepta-2,5-dien-4-ol as a colorless oil.  1H NMR (300 MHz, CDCl3, 
ppm): δ 5.56 (qquint, J = 6.6, 1.4 Hz, 2H), 4.34 (s, 1H), 1.63 (dt, J = 6.9, 1.1 Hz, 6H), 
1.47 (t, J = 1.1 Hz, 6H).  13C NMR (75 MHz, CDCl3, ppm): δ 136.1, 120.4, 81.8, 13.3, 
12.1.  HRMS (EI) calc for C9H16O, 140.1201. Found 140.1203.   
 
(2E,5E)-4-(Allyloxy)-3,5-dimethylhepta-2,5-diene (12). (2E,5E)-3,5-Dimethylhepta-
2,5-dien-4-ol (200 mg, 1.43 mmol) was added dropwise to a suspension of NaH (60% in 
oil, 114 mg, 2.85 mmol) in 6 mL THF.  After stirring at reflux for 15 min, the mixture 
was allowed to cool to rt, and allyl bromide (430 mg, 3.57 mmol) was added.  The 
mixture stirred at reflux for 4 h, was quenched with saturated aqueous NH4Cl (10 mL), 
and was extracted with ether (3 × 15 mL).  The organic layers were combined, dried over 
MgSO4, and evaporated to an oil which was purified by flash chromatography (1% 
EtOAc in hexanes) to give 210 mg (82% yield) of 12 as a colorless oil.  Spectral data 
matched those in the literature.4  1H NMR (300 MHz, CDCl3, ppm): δ 5.85–5.98 (m, 1H), 
5.55 (qq, J = 6.6, 1.1 Hz, 2H), 5.22–5.29 (m, 1H), 5.10–5.15 (m, 1H), 3.94 (br s, 1H), 
3.85 (dq, J = 5.5, 0.8 Hz, 2H), 1.63 (dq, J = 6.6, 1.1 Hz, 6H), 1.46 (d, J = 1.1 Hz, 6H).  
13C NMR (75 MHz, CDCl3, ppm): δ 135.6, 134.2, 121.2, 116.3, 88.3, 68.8, 13.3, 12.3.  
HRMS (EI) calc for C12H20O, 180.15142. Found 180.15135. 
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(2E,5E)-3,5-Dimethyl-4-(pent-4-enyloxy)hepta-2,5-diene (14). (2E,5E)-3,5-
Dimethylhepta-2,5-dien-4-ol (400 mg, 2.9 mmol) was added slowly to a suspension of 
NaH (60% in oil, 140 mg, 3.4 mmol) in 5 mL THF at rt, and some bubbling occurred.  
After 2.5 h at rt, 5-bromo-1-pentene (0.68 mL, 5.7 mmol) was added, and the mixture 
was heated to reflux for 16 h.  It was cooled to rt, carefully quenched with 20 mL water, 
and extracted with ether (3 × 25 mL).  The organic layers were combined, washed with 
brine, dried over Na2SO4, and evaporated to an oil, which was purified by flash 
chromatography (1% EtOAc in hexanes, then 10% EtOAc in hexanes) to give 130 mg 
(22% yield) of 14 as a colorless oil.  1H NMR (300 MHz, CDCl3, ppm): δ 5.76–5.90 (m, 
1H), 5.53 (qquint, J = 6.6, 1.4 Hz, 2H), 4.92–5.04 (m, 2H), 3.86 (s, 1H), 3.29 (t, J = 6.6 
Hz, 2H), 2.13 (q, J = 6.9 Hz, 2H), 1.63–1.71 (m, 2H), 1.63 (d, J = 6.6 Hz, 6H), 1.46 (s, 
6H).  13C NMR (75 MHz, CDCl3, ppm): δ 138.9, 134.6, 120.9, 114.6, 89.1, 67.5, 30.8, 
29.4, 13.4, 12.3. HRMS (EI) calc for C14H24O, 208.1827. Found 208.1828.  
 
(2E,5E)-4-(Hex-5-enyloxy)-3,5-dimethylhepta-2,5-diene (18). (2E,5E)-3,5-
Dimethylhepta-2,5-dien-4-ol (500 mg, 3.6 mmol) was added slowly to a suspension of 
NaH (60% in oil, 285 mg, 7.1 mmol) in 7 mL THF at rt, and some bubbling occurred.  
After 15 min at rt, 6-bromo-1-hexene (0.96 mL, 7.1 mmol) was added, the mixture was 
heated to reflux for 16 h.  It was cooled to rt, carefully quenched with 20 mL saturated 
aqueous NH4Cl, and extracted with ether (3 × 25 mL).  The organic layers were 
combined, washed with brine, dried over MgSO4, and evaporated to an oil, which was 
purified by flash chromatography (2% EtOAc in hexanes) to give 346 mg (44% yield) of 
18 as a colorless oil.  1H NMR (300 MHz, CDCl3, ppm): δ 5.74–5.88 (m, 1H), 5.53 (qt, J 
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= 6.6, 1.1 Hz, 2H), 4.91–5.03 (m, 2H), 3.85 (s, 1H), 3.27 (t, J = 6.4 Hz, 2H), 2.06 (q, J = 
7.1 Hz, 2H), 1.63 (d, J = 6.9 Hz, 6H), 1.54–1.60 (m, 2H), 1.40–1.52 (m, 2H), 1.45 (s, 
6H).  13C NMR (75 MHz, CDCl3, ppm): δ 139.2, 134.6, 120.9, 114.5, 89.1, 67.9, 33.9, 
29.6, 25.9, 13.3, 12.3.  HRMS (EI) calc for C15H26O, 222.1984. Found 222.1971. 
 
Allyl(((2E,5E)-3,5-dimethylhepta-2,5-dien-4-yloxy)methyl)dimethylsilane (24). 
(2E,5E)-3,5-Dimethylhepta-2,5-dien-4-ol (300 mg, 2.1 mmol) was added to a suspension 
of NaH (60% in oil, 103 mg, 2.6 mmol) in 3 mL THF and some bubbling occurred.  After 
30 min at rt, allylchloromethyldimethylsilane (0.70 mL, 0.63 g, 4.3 mmol) was added, 
and the mixture was heated to reflux for 16 h.  The reaction mixture was cooled to rt, 
quenched with 20 mL water, and extracted with ether (3 × 20 mL).  The organic layers 
were combined, washed with brine, dried over MgSO4, and evaporated to a yellow oil, 
which was purified by flash chromatography (100% hexanes) to give 349 mg (65% yield) 
of 24 as a colorless oil.  1H NMR (300 MHz, CDCl3, ppm): δ 5.81–5.95 (m, 1H), 5.51 
(qquint, J = 6.6, 1.4 Hz, 2H), 4.98 (dq, J = 17.1, 1.7 Hz, 1H), 4.85–4.91 (m, 1H), 4.28 (s, 
1H), 2.03–2.12 (m, 2H), 1.61 (dt, J = 6.9, 1.1 Hz, 6H), 1.43 (t, J = 1.1 Hz, 6H), 0.64–0.70 
(m, 2H), 0.07 (s, 6H).  13C NMR (75 MHz, CDCl3, ppm): δ 142.0, 136.5, 119.8, 112.8, 
82.3, 27.6, 16.2, 13.3, 12.1, –1.4.  HRMS (FAB) calc for C15H28OSi, 252.1910. Found 
252.1914. 
 
Allyl((2E,5E)-3,5-dimethylhepta-2,5-dien-4-yloxy)dimethylsilane (20).  
Allylchlorodimethylsilane (1.1 mL, 7.5 mmol) was added to a solution of (2E,5E)-3,5-
Dimethylhepta-2,5-dien-4-ol (1.0 g, 7.1 mmol), triethylamine (1.2 mL, 8.6 mmol), and 
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N,N-dimethylaminopyridine (44 mg, 0.4 mmol) in 30 mL CH2Cl2 at rt.  After 5 h the 
reaction was quenched with 50 mL water, the organic layer was removed, and the 
aqueous layer was extracted with ether (3 × 50 mL).  The organic layers were combined, 
washed with brine, dried over Na2SO4, and evaporated to an oil.  The oil was redissolved 
in hexanes and was filtered through a pad of neutral alumina.  The filtrate was condensed 
to give 1.30 g (76% yield) of 20 as a colorless oil.  Attempts to purify 20 by silica gel 
chromatography resulted in inconsistent yields and varying levels of purity due to product 
decomposition.  1H NMR (300 MHz, CDCl3, ppm): δ 5.70–5.85 (m, 1H), 5.52 (qquint, J 
= 6.9, 1.4 Hz, 2H), 4.80–4.90 (m, 2H), 4.30 (s, 1H), 1.61 (dt, J = 6.9, 1.1 Hz, 6H), 1.58–
1.63 (m, 2H), 1.43 (t, J = 1.1 Hz, 6H), 0.08 (s, 6H).  13C NMR (75 MHz, CDCl3, ppm): δ 
136.4, 134.8, 119.9, 113.5, 82.4, 25.1, 13.3, 12.0, –1.9.  HRMS (EI) calc for C14H26OSi, 
238.1753. Found 238.1752. 
H
Si
Cl
Ph Ph
MgBr
THF, 0 °C to 40 °C
75% yield
H
Si
Ph Ph
S2 S3  
Allyldiphenylsilane (S3).15  To a solution of S2 (2.0 g, 1.8 mL, 9.1 mmol) in 9 mL of 
THF at 0 °C was added allylmagnesium bromide (1.0 M in diethyl ether, 9.7 mL, 9.7 
mmol) over 5 min.  After 10 min at 0 °C, the cloudy mixture was warmed to 40 °C.  After 
2 h at 40 °C, the reaction was quenched with a few pieces of ice followed by 30 mL 
saturated aqueous ammonium chloride.  It was extracted with diethyl ether (3 × 30 mL), 
dried over MgSO4, and concentrated to an oil.  Purification by flash chromatography 
(100% pentane) afforded 1.53 g (75% yield) of S3 as a colorless oil.  1H NMR (300 MHz, 
CDCl3, ppm): δ 7.56–7.60 (m, 4H), 7.34–7.45 (m, 6H), 5.79–5.93 (m, 1H), 4.96 (dq, J = 
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17.1, 1.7 Hz, 1H), 4.88–4.93 (m, 1H), 4.87 (t, J = 3.6 Hz, 1H), 2.15 (dd, J = 7.7, 3.6 Hz, 
2H). 
H
Si
Ph Ph
S3
CuCl2
CuI (2.5 mol %)
THF, rt
45% yield
Cl
Si
Ph Ph
S4  
Allylchlorodiphenylsilane (S4).16  A two-neck round-bottom flask topped with a 
Schlenk filter connected to another round-bottom flask was charged with anhydrous 
CuCl2 (1.1 g, 8.0 mmol) and anhydrous CuI (19 mg, 0.10 mmol).  After 2 pump/backfills 
with argon, the powders were suspended in 8 mL of THF, allyldiphenylsilane (S3) (0.90 
g, 4.0 mmol) was added, and the orange/brown slurry was stirred vigorously.  After 16 h 
at rt, the reaction mixture was completely colorless and a white suspension was present.  
The round-bottom/Schlenk filter apparatus was inverted and placed under slight vacuum, 
and the filtrate was concentrated to a viscous oil.  Purification by distillation (Kugelrohr, 
0.4 torr, 210 °C) afforded 0.47 g (45% yield) of S4 as a pale yellow oil.  1H NMR (300 
MHz, CDCl3, ppm): δ 7.63–7.67 (m, 4H), 7.38–7.50 (m, 6H), 5.75–5.90 (m, 1H), 5.00–
5.05 (m, 1H), 4.97–5.00 (m, 1H), 2.36 (dt, J = 8.0, 1.4 Hz, 2H). 
 
Allyl((2E,5E)-3,5-dimethylhepta-2,5-dien-4-yloxy)diphenylsilane (22).  To a solution 
of allylchlorodiphenylsilane (S4) (370 mg, 1.43 mmol), triethylamine (0.28 mL, 2.0 
mmol), and N,N-dimethylaminopyridine (8.7 mg, 0.07 mmol) in 7 mL CH2Cl2 was added 
(2E,5E)-3,5-Dimethylhepta-2,5-dien-4-ol (241 mg, 1.72 mmol).  After 5 h at rt, the 
reaction was poured into 20 mL of water, the organic layer was removed, and the 
aqueous layer was extracted with CH2Cl2 (3 × 20 mL).  The organic layers were 
combined, washed with brine, dried over MgSO4, and evaporated to an oil.  Purification 
 50 
by flash chromatography afforded 359 mg (69% yield) of 22 as a colorless oil.  1H NMR 
(300 MHz, CDCl3, ppm): δ 7.55–7.59 (m, 4H), 7.31–7.39 (m, 6H), 5.71–5.85 (m, 1H), 
5.50 (tq, J = 6.9, 1.4 Hz, 2H), 4.81–4.91 (m, 2H), 4.39 (br s, 1H), 2.15 (dt, J = 8.0, 1.4 
Hz, 2H), 1.56 (dt, J = 6.9, 0.8 Hz, 6H), 1.39 (t, J = 1.1 Hz, 6H).  13C NMR (75 MHz, 
CDCl3, ppm): δ 135.89, 135.32, 135.11, 133.62, 129.86, 127.74, 120.29, 114.97, 83.04, 
22.48, 13.31, 11.94.  HRMS (EI) calc for C24H30SiO, 362.2066. Found 362.2077. 
O
12
1. 9-BBN
2. NaOH
    H2O2
    THF, rt–50 °C
    83% yield
O OH
1. (COCl)2
    DMSO
    Et3N
    CH2Cl2, –78 °C
2. [Ph3PMe]Br
    BuLi
    THF, 0 °C
     29% yield over
     2 steps
O
S5 14
 
(2E,5E)-4-(But-3-enyloxy)-3,5-dimethylhepta-2,5-diene (14).  12 (1.07 g, 5.90 mmol) 
in 3.6 mL THF was added to a solution of  9-BBN (0.5 M in THF, 14.2 mL, 7.12 mmol), 
and the solution stirred at rt.  After 5 h 3.6 mL ethanol was added, followed by 1.4 mL 
aqueous 6 M NaOH and 2.8 mL 30% H2O2, and the reaction stirred at 50 °C for 1 h.  It 
was diluted with 20 mL saturated aqueous NaHCO3 and was extracted with ether (3 × 25 
mL).  The organic layers were combined, washed with brine, dried over Na2SO4, 
evaporated to an oil, and purified by flash chromatography (20% EtOAc in hexanes) to 
give 916 mg (83% yield) of S5 as a colorless oil.  1H NMR (300 MHz, CDCl3, ppm): δ 
5.51 (qquint, J = 6.9 Hz, 1.1 Hz, 2H), 3.89 (br s, 1H), 3.79 (t, J = 5.2 Hz, 2H), 3.50 (t, J = 
5.5 Hz, 2H), 2.62 (br s, 1H), 1.84 (quint, J = 5.8 Hz, 2H), 1.64 (dt, J = 6.6 Hz, 1.1 Hz, 
6H), 1.46 (t, J = 1.4 Hz, 6H).   DMSO (0.89 mL, 12.6 mmol) was added slowly to a 
solution of oxalyl chloride (0.66 mL, 7.56 mmol) in 15 mL CH2Cl2 at –78 °C.  After 5 
min a solution of S5 (500 mg, 2.52 mmol) in 5 mL CH2Cl2 was added to the –78 °C 
reaction solution, and it stirred for 30 min.  Triethylamine (2.5 mL, 17.6 mmol) was 
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added, and after 30 min at –78 °C, the reaction slowly warmed to rt.  It was quenched 
with 40 mL water and extracted with ether (3 × 50 mL).  The organic layers were 
combined, dried over Na2SO4, and evaporated to 448 mg of the crude aldehyde as an 
orange oil, which was used in the next step without further purification (attempts to 
purify this aldehyde by silica gel chromatography resulted in product decomposition and 
low (~30%) isolated yields).  To a suspension of triphenylmethylphosphonium bromide 
(2.15 g, 6.0 mmol) in 20 mL THF at 0 °C was added n-butyllithium (2.5 M in hexanes, 
2.0 mL, 5.0 mmol).  After 20 min a solution of the crude aldehyde (448 mg, 2.3 mmol) in 
5 mL THF was added slowly to the orange reaction mixture, and it stirred at 0 °C for 1 h.  
It was quenched with 30 mL saturated aqueous NH4Cl and extracted with ether (3 × 25 
mL).  The organic layers were combined, dried over MgSO4, and evaporated to an oil, 
which was purified by flash chromatography (1% EtOAc in hexanes) to give 179 mg of a 
colorless oil.  To a solution of the oil in 10 mL CH2Cl2 was added 3% hydrogen peroxide, 
and the mixture was shaken for 15 minutes.  The organic layer was removed, dried over 
Na2SO4, evaporated to an oil, and filtered through a plug of silica gel (1% EtOAc in 
hexanes).  The filtrate was concentrated to 145 mg (29% yield over 2 steps) of 14 as a 
colorless oil.  1H NMR (300 MHz, CDCl3, ppm): δ 5.77–5.92 (m, 1H), 5.53 (qquint, J = 
6.9, 1.4 Hz, 2H), 4.98–5.11 (m, 2H), 3.88 (s, 1H), 3.33 (t, J = 6.9 Hz, 2H), 2.33 (q, J = 6.9 
Hz, 2H), 1.63 (d, J = 6.6 Hz, 6H), 1.46 (s, 6H).  13C NMR (75 MHz, CDCl3, ppm): δ 
136.0, 134.5, 121.0, 116.2, 89.1, 67.6, 34.7, 13.3, 12.3.  HRMS (EI) calc for C13H22O, 
194.1671. Found 194.1679. 
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Et2O, –40 °C
60% yield
CuBr (cat.)
1.
2.
S6 S7  
(2E,7E)-3,7-Dimethylnona-2,7-dien-5-ol (S8).  Titanocene dichloride (212 mg, 0.85 
mmol) was added to a solution of 2-butyne (2.4 mL, 30 mmol) and isobutylmagnesium 
bromide (2.0 M in diethyl ether, 15 mL, 30 mmol) in 30 mL Et2O, and the solution stirred 
at rt for 1 h.  This brown solution was slowly transferred via syringe to a suspension of 
CuBr (397 mg, 2.8 mmol) in Et2O (75 mL) at –78 °C.  After 5 min epichlorohydrin  (2.2 
mL, 28 mmol) was added slowly to the mixture.  It stirred at –78 °C for 3 h, and was 
allowed to warm to –40 °C where it continued stirring for 48 h.  The reaction mixture 
was poured into 100 mL aqueous 1 N HCl and was extracted with ether (3 × 100 mL).  
The organic layers were combined, dried over MgSO4, and evaporated to an oil, which 
was purified by flash chromatography (10% EtOAc in hexanes) to give 2.83 g (68% 
yield) of the chlorohydrin S6 as a yellow oil.  1H NMR (300 MHz, CDCl3, ppm): δ 5.36 
(qq, J = 6.6, 1.1 Hz, 1H), 3.89–3.97 (m, 1H), 3.61 (dd, J = 11.0, 4.1 Hz , 1H), 3.50 (dd, J 
= 11.0, 6.3 Hz, 1H), 2.29 (dd, J = 13.5, 5.5 Hz, 1H), 2.20 (dd, J = 13.5, 8.0 Hz, 1H), 2.04 
(br s, 1H), 1.66 (t, J = 1.1 Hz, 3H), 1.62 (dt, J = 6.9 Hz, 0.8 Hz, 3H).  The chlorohydrin 
S6 (2.8 g, 19 mmol) was added slowly to a suspension of NaH (60% in oil, 1.13 g, 28 
mmol) in 50 mL THF, and the mixture stirred at reflux for 16 h.  It was cooled to rt, 
quenched with saturated aqueous NH4Cl until pH = 9 was reached, and was extracted 
with ether (3 × 50 mL).  The organic layers were combined, dried over MgSO4, and 
evaporated to a yellow oil, which was purified by flash chromatography (1% Et2O in 
pentane) to give 1.08 g (51% yield) of the epoxide S7 as a pale yellow oil.  1H NMR (300 
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MHz, CDCl3, ppm): δ 5.34 (qq, J = 6.6, 1.1 Hz, 1H), 2.96–3.02 (m, 1H), 2.77 (dd, J = 
4.9, 3.8 Hz, 1H), 2.49 (dd, J = 4.9, 2.7 Hz, 1H), 2.25 (dd, J = 14.8, 6.0 Hz, 1H), 2.16 (dd, 
J = 14.5, 5.5 Hz, 1H), 1.69 (t, J = 1.1 Hz, 3H), 1.61 (dq, J = 6.6, 1.1 Hz, 3H).  Titanocene 
dichloride (69 mg, 0.28 mmol) was added to a solution of 2-butyne (0.8 mL, 10 mmol) 
and isobutylmagnesium bromide (2.0 M in diethyl ether, 4.9 mL, 10 mmol) in 10 mL 
Et2O, and the solution stirred at rt for 1 h.  This brown solution was slowly transferred via 
syringe to a suspension of CuBr (128 mg, 0.9 mmol) in Et2O (25 mL) at –78 °C.  After 5 
min the epoxide S7 (1.0 g, 9 mmol) was added slowly to the mixture.  It stirred at –78 °C 
for 2 h, and was allowed to warm to –40 °C where it continued stirring for 24 h.  The 
reaction mixture was poured into 75 mL aqueous 1 N HCl and was extracted with ether 
(3 × 50 mL).  The organic layers were combined, dried over Na2SO4, and evaporated to 
an oil, which was purified by flash chromatography (7% EtOAc in hexanes) to give 894 
mg (60% yield, 21% over 3 steps) of S8 as a pale yellow oil.  1H NMR (300 MHz, 
CDCl3, ppm): δ 5.30 (q, J = 6.6 Hz, 2H), 3.75–3.82 (m, 1H), 2.01–2.15 (m, 4H), 1.79 (d, 
J = 1.7 Hz, 1H), 1.62 (s, 6H), 1.59 (d, J = 6.6 Hz, 6H).  13C NMR (75 MHz, CDCl3, ppm): 
δ 133.0, 122.2, 66.6, 47.7, 16.0, 13.7.  HRMS (EI) calc for C11H20O, 168.1514. Found 
168.1515. 
 
(2E,7E)-5-(Allyloxy)-3,7-dimethylnona-2,7-diene (26).  Alcohol S8 (200 mg, 1.2 
mmol) was added dropwise to a suspension of NaH (60% in oil, 95 mg, 2.4 mmol) in 
5 mL THF.  After stirring at reflux for 15 min, the mixture was allowed to cool to rt, and 
allyl bromide (360 mg, 3.0 mmol) was added.  The mixture stirred at reflux for 12 h, was 
quenched with saturated aqueous NH4Cl (30 mL), and was extracted with ether (3 × 30 
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mL).  The organic layers were combined, dried over MgSO4, and evaporated to an oil 
which was purified by flash chromatography (1.5% EtOAc in hexanes) to give 180 mg 
(73% yield) of S8 as a colorless oil.  1H NMR (300 MHz, CDCl3, ppm): δ 5.80–5.93 (m, 
1H), 5.20–5.28 (m, 3H), 5.09–5.13 (m, 1H), 3.98 (dt, J = 5.4, 1.5 Hz, 2H), 3.50–3.58 (m, 
1H), 2.18 (dd, J = 13.2, 6.9 Hz, 2H), 2.07 (dd, J = 13.5, 6.0 Hz, 2H), 1.62 (t, J = 1.2 Hz, 
6H), 1.56–1.59 (m, 6H). 
 
Allyl((2E,7E)-3,7-dimethylnona-2,7-dien-5-yloxy)dimethylsilane (28).  To a solution 
of S8 (150 mg, 0.9 mmol), triethylamine (0.25 mL, 1.8 mmol), and N,N-
dimethylaminopyridine (5 mg, 0.04 mmol) in 5 mL CH2Cl2 was added 
allylchlorodimethylsilane (0.20 mL, 1.3 mmol).  After stirring at rt for 16 h, the reaction 
was quenched with 10 mL water and extracted with diethyl ether (3 × 20 mL).  The 
organic layers were combined, washed with brine, dried over Na2SO4, and evaporated to 
an oil, which was purified by flash chromatography (1% EtOAc in hexanes) to give 209 
mg (88% yield) of 28 as a colorless oil.  1H NMR (300 MHz, CDCl3, ppm): δ 5.70–5.84 
(m, 1H), 5.23 (qq, J = 6.6, 1.4 Hz, 2H), 4.81–4.89 (m, 2H), 3.85 (quint, J = 6.3 Hz, 1H), 
2.05–2.08 (m, 4H), 1.60 (t, J = 1.1 Hz, 6H), 1.58 (dt, J = 6.6, 0.8 Hz, 6H), 1.54–1.57 (m, 
2H), 0.05 (s, 6H).  13C NMR (75 MHz, CDCl3, ppm): δ 134.7, 133.0, 121.7, 113.5, 70.5, 
48.2, 25.4, 16.5, 13.6, –1.7. HRMS (EI) calc for C16H30OSi, 266.2066. Found 266.2070. 
 
General Procedure A:  asymmetric ring-closing reactions with 1a, 2a, 4a, and 5a.  
Triene was added to a solution of dichloride catalyst (1–2 mol %) in CH2Cl2 (0.055 M), 
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and the reaction stirred at 40 °C for 2 h.  The solvent was evaporated, and the remaining 
residue was purified by flash chromatography to yield the desired cyclic diene.   
 
General Procedure B:  asymmetric ring-closing reactions with 1b, 2b, 4b, and 5b.  A 
solution of NaI (25 equiv. relative to catalyst) and dichloride catalyst (4 mol %) in THF 
was stirred at rt for 1 h.  Triene (0.055 M) was added, and the solution stirred at 40 °C for 
2 h.  The solvent was evaporated, and the remaining residue was purified by flash 
chromatography to yield the desired cyclic diene.   
 
(S,E)-2-(But-2-en-2-yl)-3-methyl-2,5-dihydrofuran (13).  Following general procedure 
B, 12 (40 mg, 0.22 mmol), 2a (8.9 mg, 0.0089 mmol), and NaI (33 mg, 0.22 mmol) in 4 
mL THF gave 19.8 mg (64% yield) of 13 as a pale yellow oil (5% Et2O in pentane) in 
90% ee.  Chiraldex G-TA, 1mL/min, 60 °C for 60 min, retention times = 21.9 (major) 
and 23.4 (minor) min.  [α]D25 = +116.5 (CHCl3, c = 0.55).  1H NMR (300 MHz, CDCl3, 
ppm): δ 5.56 (quint, J = 1.6 Hz, 1H), 5.52 (q, J = 6.9 Hz, 1H), 4.88 (br s, 1H), 4.53–4.68 
(m, 2H), 1.64 (dq, J = 6.9, 1.1 Hz, 3H), 1.56 (quint, J = 1.4 Hz, 3H), 1.47 (quint, J = 1.4 
Hz, 3H).  13C NMR (75 MHz, CDCl3, ppm): δ 137.2, 135.6, 123.8, 121.5, 95.0, 75.6, 
13.5, 12.4, 10.1.  HRMS (EI) calc. for C9H14O, 138.1045. Found 138.1040. 
 
(S,E)-6-(But-2-en-2-yl)-5-methyl-3,6-dihydro-2H-pyran (15).  Following general 
procedure B, 14 (40 mg, 0.21 mmol), 2a (8.2 mg, 0.0082 mmol), and NaI (31 mg, 
0.21 mmol) in 3.8 mL THF gave 24.1 mg (77% yield) of 15 as a pale yellow oil (3% 
Et2O in pentane) in 90% ee.  Chiraldex G-TA, 1mL/min, 60 °C for 60 min, retention 
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times = 30.6 (major) and 34.7 (minor) min.  [α]D26 = +43.0 (CHCl3, c = 0.69).  1H NMR 
(300 MHz, CDCl3, ppm): δ 5.64–5.68 (m, 1H), 5.53 (q, J = 6.6 Hz, 1H), 4.29 (s, 1H), 
3.88–3.94 (m, 1H), 3.53–3.61 (m, 1H), 2.19–2.32 (m, 1H), 1.85–1.96 (m, 1H), 1.64 (dd, J 
= 6.6, 1.1 Hz, 3H), 1.54 (t, J = 1.4 Hz, 3H), 1.47 (q, J = 1.4 Hz, 3H).  13C NMR (75 MHz, 
CDCl3, ppm): δ 134.9, 134.5, 125.2, 121.5, 84.1, 62.9, 25.8, 19.7, 13.5, 11.5.  HRMS (EI) 
calc for C10H16O, 152.1201. Found 152.1204. 
 
(S,Z)-7-((E)-But-2-en-2-yl)-6-methyl-2,3,4,7-tetrahydrooxepine (17).  Following a 
modified version of general procedure A, 16 (40 mg, 0.19 mmol) was added to a solution 
of 1a (2.1 mg, 0.0019 mmol) in 3.5 mL CH2Cl2, and the reaction stirred at 40 °C.  After 2 
h, an additional portion of 1a (2.1 mg, 0.0019 mmol) was added, and the solution stirred 
at 40 °C for an additional 2 h.  The solvent was removed by evaporation, and the residue 
was purified by flash chromatography (4% EtOAc in hexanes) to give 29.4 mg (92% 
yield) of 17 as a yellow oil in 76% ee.  Chiraldex G-TA, 1mL/min, 60 °C for 90 min, 
retention times = 75.1 (minor) and 76.6 (major) min.  [α]D24 = +164.0 (CHCl3, c = 0.90).  
1H NMR (300 MHz, CDCl3, ppm): δ 5.57–5.62 (m, 1H), 5.51 (q, J = 6.6 Hz, 1H), 4.26 (s, 
1H), 3.85–3.92 (m, 1H), 3.57–3.66 (m, 1H), 2.48–2.59 (m, 1H), 1.87–2.03 (m, 2H), 1.67–
1.80 (m, 1H), 1.67 (t, J = 2.2 Hz, 3H), 1.65 (d, J = 6.6 Hz, 3H), 1.50 (s, 3H).  13C NMR 
(75 MHz, CDCl3, ppm): δ 137.2, 134.6, 125.3, 124.0, 91.4, 66.3, 29.2, 23.4, 21.9, 13.5, 
12.5.  HRMS (EI) calc for C11H18O, 166.1358. Found 166.1353. 
 
(S,Z)-8-((E)-But-2-en-2-yl)-7-methyl-3,4,5,8-tetrahydro-2H-oxocine (19).  Following 
general procedure B, 18 (14 mg, 0.061 mmol), 4a (3 mg, 0.003 mmol), and NaI (9 mg, 
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0.06 mmol) in 1.1 mL THF afforded 19 as only 5% of a mixture of unreacted 18 and 
other olefinic products in 88% ee.  Chiraldex G-TA, 1mL/min, 60 °C for 90 min, 
retention times = 57.4 (minor) and 58.7 (major) min. 
 
(S,E)-6-(But-2-en-2-yl)-2,2,5-trimethyl-3,6-dihydro-2H-1,2-oxasiline (21).  Following 
general procedure A, 20 (0.95 g, 4.0 mmol) and 1a (35 mg, 0.032 mmol) in 72 mL 
CH2Cl2 gave 0.60 g (77% yield) of 21 as a yellow oil (3% EtOAc in hexanes) in 92% ee.  
Chiraldex G-TA, 1mL/min, 60 °C for 60 min, retention times = 28.6 (minor) and 29.9 
(major) min.  [α]D25 = +195.4 (CHCl3, c = 0.96).  1H NMR (300 MHz, CDCl3, ppm): δ 
5.69 (dquint, J = 7.7, 1.4 Hz, 1H), 5.49 (q, J = 6.6 Hz, 1H), 4.54 (s, 1H), 1.63 (dd, J = 6.6, 
1.1 Hz, 3H), 1.54 (t, J = 1.1 Hz, 3H), 1.51 (s, 3H), 1.29–1.39 (m, 1H), 1.12–1.21 (m, 1H), 
0.19 (s, 3H), 0.13 (s, 3H).  13C NMR (75 MHz, CDCl3, ppm): δ 136.9, 136.0, 122.9, 
120.4, 83.4, 22.0, 13.5, 12.5, 10.7, 0.3, –0.6.  HRMS (EI) calc for C11H20OSi, 196.1284.  
Found 196.1281. 
 
(S,Z)-7-((E)-But-2-en-2-yl)-3,3,6-trimethyl-2,3,4,7-tetrahydro-1,3-oxasilepine (25).  
Following general procedure A, 24 (40 mg, 0.16 mmol) and 1a (1.7 mg, 0.0016 mmol) in 
2.9 mL CH2Cl2 gave 21.7 mg (65% yield) of 25 as a yellow oil (2% EtOAc in hexanes) in 
92% ee.  Chiraldex G-TA, 1mL/min, 60 °C for 60 min, retention times = 28.7 (minor) 
and 29.8 (major) min.  [α]D25 = +184.3 (CHCl3, c = 0.75).  1H NMR (300 MHz, CDCl3, 
ppm): δ 5.66 (t, J = 7.4 Hz, 1H), 5.49 (q, J = 6.9 Hz, 1H), 4.49 (s, 1H), 2.55–2.67 (m, 
1H), 2.02–2.12 (m, 1H), 1.68 (t, J = 1.1 Hz, 3H), 1.64 (d, J = 6.9 Hz, 3H), 1.56 (s, 3H), 
0.75–0.86 (m, 2H), 0.16 (s, 3H), 0.14 (s, 3H).  13C NMR (75 MHz, CDCl3, ppm): δ 137.2, 
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136.5, 128.8, 121.8, 84.0, 22.6, 21.9, 16.8, 13.5, 11.8, 0.9, –0.3.  HRMS (EI) calc for 
C12H22OSi, 210.1440. Found 210.1449. 
 
(S,Z)-2,2,5-Trimethyl-7-((E)-2-methylbut-2-enyl)-2,3,6,7-tetrahydro-1,2-oxasilepine 
(29).  Following general procedure B, 28 (40 mg, 0.15 mmol), 2a (6.0 mg, 0.006 mmol), 
and NaI (23 mg, 0.15 mmol) in 2.7 mL THF gave 33.1 mg (98% yield) of 29 as a light 
yellow oil (2% EtOAc in hexanes) in 78% ee.  CP Chirasil-Dex-CB, 1 mL/min, 60 °C for 
250 min, retention times = 205.5 (major) and 213.8 (minor) min.  [α]D24 = +8.3 (CHCl3, c 
= 0.99).  1H NMR (300 MHz, CDCl3, ppm): δ 5.53 (t, J = 7.4 Hz, 1H), 5.24 (qq, J = 6.6, 
1.1 Hz, 1H), 3.97–4.05 (m, 1H), 2.21–2.36 (m, 2H), 2.01–2.10 (m, 2H), 1.70 (s, 3H), 
1.62 (s, 3H), 1.59 (d, J = 6.6 Hz, 3H), 1.54–1.60 (m, 1H), 1.31–1.39 (m, 1H), 0.11 (s, 
3H), 0.08 (s, 3H).  13C NMR (75 MHz, CDCl3, ppm): δ 134.3, 133.4, 121.3, 121.2, 71.1, 
49.2, 41.3, 25.9, 18.0, 16.2, 13.6, 0.4, –1.4.  HRMS (EI) calc for C13H24OSi, 224.1597. 
Found 224.1598.   
 
(S,E)-6-(But-2-en-2-yl)-5-methyl-2,2-diphenyl-3,6-dihydro-2H-1,2-oxasiline (23). 
Following general procedure A, 22 (25 mg, 0.069 mmol) and 1a (1.5 mg, 0.0014 mmol) 
in 1.3 mL CH2Cl2 gave crude 23 as a pale yellow oil (5% Et2O in pentane) in 80% ee.  
Chiral SFC (supercritical CO2 with 5%–50% MeOH ramp over 10 min), ADH, 
4 mL/min, 100 bar, 214 nm detector wavelength, retention times = 1.44 (major) and 1.99 
(minor) min.  1H NMR (300 MHz, CDCl3, ppm): δ 7.57–7.64 (m, 4H), 7.32–7.43 (m, 
6H), 5.81–5.85 (m, 1H), 5.55 (q, J = 6.6 Hz, 1H), 4.76 (br s, 1H), 1.84 (dq, J = 17.3, 2.8 
Hz, 1H), 1.69–1.78 (m, 1H), 1.64 (d, J = 6.6 Hz, 3H), 1.63 (s, 3H), 1.53 (s, 3H).  13C 
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NMR (75 MHz, CDCl3, ppm): δ 137.02, 136.62, 136.08, 135.83, 134.73, 134.59, 130.20, 
130.07, 128.09, 128.04, 123.32, 120.02, 84.27, 22.20, 13.59, 11.03, 10.50.  HRMS (EI) 
calc for C21H24OSi, 320.1596. Found 320.1597. 
 
(E)-4-Methyl-2-(2-methylbut-2-enyl)-3,6-dihydro-2H-pyran (27).  Following general 
procedure B, 26 (23 mg, 0.11 mmol), 2a (5 mg, 0.005 mmol), and NaI (17 mg, 0.11 
mmol) in 2.0 mL THF afforded a crude mixture of 27 (>95%) in 35% ee.  Chiraldex G-
TA, 1mL/min, 60 °C for 70 min, retention times = 60.6 (minor) and 62.4 (major).  1H 
NMR (300 MHz, CDCl3, ppm) for 42: δ 5.39 (br s, 1H), 5.26–5.30 (m, 1H), 4.11–4.14 
(m, 2H), 3.58–3.67 (m, 1H), 2.32 (dd, J = 13.7, 6.9 Hz, 1H), 2.11 (dd, J = 13.7, 6.3 Hz, 
1H), 1.73–1.90 (m, 2H), 1.68 (s, 3H), 1.63 (d, J = 0.8 Hz, 3H), 1.59 (dd, J = 6.9, 0.8 Hz, 
3H). 
 
Allyl((2E,5E)-hepta-2,5-dien-4-yloxy)dimethylsilane (38).  To a solution of imidazole 
(486 mg, 7.1 mmol) in DMF (5 mL) was added the known alcohol (2E,5E)-hepta-2,5-
dien-4-ol17 (200 mg, 1.8 mmol) and allylchlorodimethylsilane (0.40 mL, 2.7 mmol).  
After 16 h at rt, the reaction mixture was diluted with 10 mL of water and extracted with 
Et2O (3 × 15 mL).  The combined organic layers were washed with aqueous 1 M CuSO4, 
water, dried over MgSO4, and concentrated.  Purification by flash chromatography (2% 
ethyl acetate in hexanes) afforded 253 mg (67% yield) of 38 as a colorless oil.  1H NMR 
(300 MHz, CDCl3, ppm): δ 5.72–5.86 (m, 1H), 5.54–5.65 (m, 2H), 5.42–5.50 (m, 2H), 
4.83–4.92 (m, 2H), 4.52 (tquint, J = 6.0, 0.8 Hz, 1H), 1.68 (dt, J = 6.0, 0.8 Hz, 6H), 1.62 
(dt, J = 8.0, 1.1 Hz, 2H), 0.11 (s, 6H).  Upon exposure to olefin metathesis catalyst 
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(H2IMes)RuCl2(=CHPh), it was completely converted into a complex mixture of volatile 
products. 
1. Cp2TiCl2 (3 mol %)
MgBr
2.  ethyl formate
     Et2O, 0 °C to rt
     68% yield
OH
S9  
(3E,6E)-4,6-Diethylnona-3,6-dien-5-ol (S9).  To a solution of 3-hexyne (1.4 mL, 1.0 g, 
12.2 mmol) and isobutylmagnesium bromide (2.0 M in Et2O, 6.1 mL, 12.2 mmol) in 12 
mL of Et2O was added titanocene dichloride (85 mg, 0.34 mmol).  After 1 h at rt, the 
solution was cooled to 0 °C and ethyl formate (0.44 mL, 0.40 g, 5.5 mmol), in 0.5 mL 
Et2O, was added dropwise.  After 5 min at 0 °C, the solution was allowed to warm to rt.  
After 1 h at rt, the reaction was quenched with saturated aqueous ammonium chloride 
(carefully; bubbling occurred), and it was filtered through a pad of celite, which was 
washed with water and diethyl ether.  The organic layer was removed from the filtrate, 
and the remaining aqueous layer was extracted with 2 × Et2O.  The combined organic 
layers were dried over Na2SO4 and concentrated.  Purification by flash chromatography 
(10% ethyl acetate in hexanes) afforded 0.73 g (68% yield) of S9 as a yellow oil.  1H 
NMR (300 MHz, CDCl3, ppm): δ 5.47 (t, J = 7.2 Hz, 2H), 4.45 (br s, 1H), 1.98–2.13 (m, 
6H), 1.81–1.93 (m, 2H), 1.44 (br s, 1H), 1.00 (t, J = 7.4 Hz, 6H), 0.94 (t, J = 7.4 Hz, 6H). 
OOH
S9
Br
NaH
THF, 65 °C
93% yield
40  
(3E,6E)-5-(Allyloxy)-4,6-diethylnona-3,6-diene (40).  To a suspension of 95% NaH (24 
mg, 1.0 mmol) in 1.5 mL of THF was added S9 (100 mg, 0.51 mmol).  After 10 min at rt, 
allyl bromide (filtered through neutral alumina, 66 µL, 0.76 mmol) was added.  After 16 
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h at 65 °C, the reaction mixture was diluted with 10 mL Et2O, carefully quenched with 10 
mL of water, and extracted with 3 × 20 mL of Et2O.  The combined organic layers were 
washed with brine (20 mL), dried over MgSO4, and concentrated.  Purification by flash 
chromatography (1% ethyl acetate in hexanes) afforded 112 mg (93% yield) of 40 as a 
colorless oil.  1H NMR (300 MHz, CDCl3, ppm): δ 5.86–5.99 (m, 1H), 5.45 (t, J = 7.2 Hz, 
2H), 5.26 (dq, J = 17.3, 1.9 Hz, 1H), 5.10–5.16 (m, 1H), 4.00 (br s, 1H), 3.89 (dt, J = 5.5, 
1.4 Hz, 2H), 1.96–2.14 (m, 6H), 1.78–1.90 (m, 2H), 0.99 (t, J = 7.4 Hz, 6H), 0.92 (t, J = 
7.4 Hz, 6H).  13C NMR (75 MHz, CDCl3, ppm): δ 138.45, 135.67, 129.25, 116.20, 86.02, 
68.92, 21.10, 20.61, 14.66, 14.20.  HRMS (EI) calc for C16H28O, 236.2140. Found 
236.2140.   
 
(E)-3-Ethyl-2-(hex-3-en-3-yl)-2,5-dihydrofuran (41).  Following general procedure B, 
40 (12 mg, 0.050 mmol), 2a (2 mg, 0.0020 mmol), and NaI (7.5 mg, 0.050 mmol) in 0.9 
mL THF gave a crude residue that was passed down a pipet column (5% ethyl acetate in 
hexanes) to afford 41 (>95% conv.) in 29% ee.  Chiraldex G-TA, 1mL/min, 50 °C for 15 
min, retention times = 2.7 (major) and 3.1 (minor) min.  1H NMR (300 MHz, CDCl3, 
ppm): δ 5.55–5.57 (m, 1H), 5.36 (t, J = 14.6 Hz, 1H), 4.95 (br s, 1H), 4.65–4.72 (m, 1H), 
4.56–4.62 (m, 1H), 1.80–2.13 (m, 6H), 1.07 (t, J = 7.4 Hz, 3H), 0.99 (t, J = 7.4 Hz, 3H), 
0.97 (t, J = 7.4 Hz, 3H).  13C NMR (75 MHz, CDCl3, ppm): δ 144.12, 140.19, 131.73, 
119.40, 94.54, 75.51, 21.13, 20.36, 19.40, 15.01, 14.55, 12.03.  HRMS (EI) calc. for 
C12H20O, 180.1514. Found 180.1510. 
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Absolute Stereochemistry Proof.  All four chiral ruthenium catalysts tested in this study 
(1, 2, 4, and 5) afforded the same enantiomer of the product for any given substrate in 
Tables 3.1–4.3, and the absolute stereochemistry of a few of the products was determined 
(Figure S3.1).  The absolute stereochemistry of 31-ent was proven by an independent 
synthesis using a Sharpless kinetic resolution.4  Compound 31-ent was also made with 
chiral molybdenum catalysts, and a GC trace using a Chiraldex GTA column was used to 
determine the enantioselectivities of the reactions.  The chiral ruthenium complex 2a 
catalyzed the formation of 31, which was also separated on a Chiraldex GTA column.  
The GC traces showed that chiral catalyst 2a, and therefore all the catalysts used in this 
study, afforded 31 in the absolute configuration shown in Table 3.3.  The absolute 
configuration of 13 was determined by exposing it to ethenolysis conditions, which 
generated the same enantiomer of 31 that was obtained by the ARCM reaction of 30.  
Finally, compound 21 was oxidized to diol S10 and exposed to a one-pot 
mesylation/intramolecular nucleophilic displacement sequence to afford the same 
enantiomer of 13 that was obtained by the ARCM of 12.  Chiral, cyclic products derived 
from a triene lacking terminal methyl groups (30), containing cis methyl groups and an 
alkenyl ether (12), and containing cis methyl groups and a dimethylsilyl alkenyl ether 
(20) all had the same absolute stereochemistry, which suggests that all of the products 
synthesized with 1, 2, 3, 4 or 5 have the same absolute configurations.   
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O 3a (2 mol %)
CH2Cl2, 40 °C, 2 h
13
35% ee
 (5 mol %)
60 psi ethylene
CH2Cl2, 40 °C
16 h 31
33% ee
O 8a (2 mol %)
CH2Cl2, 40 °C, 2 h
Same GC trace
Chiral GTA column
O
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39% ee
30
OO
12
O
Si
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16a (3 mol %)
NaI, THF, 40 °C, 2 h
O
Si
21
87% ee
MsCl (1 equiv)
Et3N
CH2Cl2
rt, 15 min
KF
KHCO3
H2O2
MeOH/THF
(1:1)
rt, 16 h
OH
OH O
 13
86% ee
S10
Same GC trace
Chiral GTA column
 
Figure S3.1. Absolute stereochemistry proof. 
                                                
1 Funk, T. W.; Berlin, J. M.; Grubbs, R. H. J. Am. Chem. Soc. 2006, 128, 1840. 
2 Funk, T. W. PhD thesis, California Institute of Technology, 2005  
3 For recent reviews on asymmetric olefin metathesis, see (a) Hoveyda, A. H. In 
Handbook of Metathesis; Grubbs, R. H., Ed.; Wiley-VCH: Weinheim, Germany, 2003; 
Chapter 2.3. (b) Schrock, R. R.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2003, 42, 4592. 
(c) Hoveyda, A. H.; Schrock, R. R. Chem. Eur. J. 2001, 7, 945. 
4 La, D. S.; Alexander, J. B.; Cefalo, D. R.; Graf, D. D.; Hoveyda, A. H.; Schrock, R. R. 
J. Am. Chem. Soc. 1998, 120, 9720. 
5 Zhu, S. S.; Cefalo, D. R.; La, D. S.; Jamieson, J. Y.; Davis, W. M.; Hoveyda, A. H.; 
Schrock, R. R. J. Am. Chem. Soc. 1999, 121, 8251. 
6 (a) Seiders, T. J.; Ward, D. W.; Grubbs, R. H. Org. Lett. 2001, 3, 3225. During the 
course of our work two more reports on Ru-catalyzed ARCM were published: (b) Van 
 64 
                                                                                                                                            
Veldhuizen, J. J.; Gillingham, D. G.; Garber, S. B.; Kataoka, O.; Hoveyda, A. H. J. Am. 
Chem. Soc. 2003, 125, 12502. (c) Van Veldhuizen, J. J.; Garber, S. B.; Kingsbury, J. S.; 
Hoveyda, A. H. J. Am. Chem. Soc. 2002, 124, 4954.  
 
7 Allowing the hydrogen instead of the non-metal bound vinyl group to interact with the 
iodide also puts the vinyl group in the pseudo-equatorial position of the ring (see 45).  
8 Evidence for cis-coordination: (a) Trnka, T. M.; Day, M. W.; Grubbs, R. H. 
Organometallics 2001, 20, 3845.  Evidence for trans-coordination: (b) Tallarico, J. A.; 
Bonitatebus, Jr., P. J.; Snapper, M. L. J. Am. Chem. Soc. 1997, 119, 7157. (c) Romero, P. 
E.; Piers, W. E. J. Am. Chem. Soc. 2005, 127, 5032. 
9 (a) Costabile, C.; Cavallo, L. J. Am. Chem. Soc.2004, 126, 9592. (b) Adlhart, C.; 
Chen, P. J. Am. Chem. Soc. 2004, 126, 3496. (c) Fomine, S.; Vargas, S. M.; 
Tlenkopatchev, M. A. Organometallics 2003, 22, 93. (d) Cavallo, L. J. Am. Chem. Soc. 
2002, 124, 8965. (e) Vyboishchikov, S. F.; Bühl, M.; Thiel, W. Chem. Eur. J. 2002, 8, 
3962. 
10 The X-ray crystal structure of an analogue of 2a in reference 6a shows that the plane 
of the N-bound aryl ring is not orthogonal to the plane of the NHC.  QM/MM 
calculations in reference 9a concluded that the N-bound aryl rings of a substrate-bound 
ruthenium alkylidene also are not orthogonal to the plane of the NHC. 
11 Computations suggest that as the halide ligand increases in size (van der Waals radii) 
from Cl— to I—, the X—Ru—X bond angle also increases.  A larger bond angle positions 
the halides closer to the Ru=CHR moiety (a smaller angle means the halides are pulled 
 65 
                                                                                                                                            
away from the alkylidene), which puts the halides in closer proximity to the reacting 
olefin, creating a smaller pocket, and therefore a more selective reaction.  See reference 
9a. 
12 Sanford, M. S.; LOve, J. A.; Grubbs, R. H. J. Am. Chem. Soc. 2001, 123, 6543. 
 
13 Palucki, M.; Finney, N. S.; Pospisil, P. J.; Güler, M. L.; Ishida, T.; Jacobsen, E. N. J. 
Am. Chem. Soc. 1998, 120, 948. 
14 Kiely, A. F.; Jernelius, J. A.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2002, 
124, 2868. 
15 Robertson, J.; Hall, M. J.; Stafford, P. M.; Green, S. P. Org. Biomol. Chem. 2003, 1, 
3758. 
16 Kunai, A.; Kawakami, T.; Toyoda, E.; Ishikawa, M. Organometallics 1992, 11, 2708. 
17 Underiner, T. L.; Goering, H. L. J. Org. Chem. 1990, 55, 2757. 
